 |
 |
 | NELSON TEXTBOOK OF PEDIATRICS
|  |
 |  |  |
 |
 |
To order this title, and for more information, click here
Eighteenth Edition
By
Robert Kliegman, MD, Professor and Chair, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
Richard Behrman, MD, Executive Chair, Pediatric Education Steering Committee, Federation of Pediatric Organizations, Menlo Park, CA; Clinical Professor
of Pediatrics, Stanford University and the University of California, San Francisco, CA; George Washington University, Washington, DC
Hal Jenson, MD, Chair, Department of Pediatrics, Director, Center for Pediatric Research, and Senior Vice-President for Academic Affairs, Eastern
Virginia Medical School and Children's Hospital of the King's Daughters, Norfolk, VA
Bonita Stanton, MD, Schotanus Professor and Chair, Department of Pediatrics, Wayne State University, Detroit, MI, USA
Description
For nearly three quarters of a century, Nelson Textbook of Pediatrics has been the world's most trusted resource for best approaches to
pediatric care. Now in full color for easier referencing, this New Edition continues the tradition, incorporating a wealth of exciting
updates and changes?ensuring you have access to today's authoritative knowledge to best diagnose and treat every pediatric patient you
see. Whether you're treating patients in the office or in the hospital, or preparing for the boards, Nelson Textbook of Pediatrics, 18th
Edition is your comprehensive guide to providing the best possible care.
Contents
Part I: The Field of Pediatrics
1 Overview of Pediatrics
2 Quality and Safety in Healthcare for Children
3 Ethics in Pediatric
Care
4 Cultural Issues in Pediatric Care
5 Maximizing Children?s Health: Screening, Anticipatory Guidance, and Counseling
Part
II: Growth, Development, and Behavior
6 Overview and Assessment of Variability
6.1 Assessment of Fetal
Growth and Development
7 The Newborn
8 The First Year
9 The Second Year
10 Preschool Years
11 Middle Childhood
12 Adolescence
13 Sexual
Behavior
13.1 The Development of Sexual Behavior
13.2 Gender Identity Disorder (GID)
13.3 Adolescent Homosexuality
14 Assessment of
Growth
15 Developmental Screening and Surveillance
16 Child Care: How Pediatricians Can Support Children and Famillies
17 Separation,
Loss, and Bereavement
18 Sleep Medicine
Part III: Child and Adolescent Psychology
19 Assessment
and Interviewing
20 Psychological Treatment of Children and Adolescents
20.1 Illness and Death
20.2 Psychopharmacology
20.3 Psychotherapy
20.4 Psychiatric Hospitalization
21 Psychosomatic Illness
22 Vegetative Disorders
22.1 Rumination Disorders
22.2 Pica
22.3 Enuresis (Bedwetting)
22.4 Encopresis
23 Habit and Tic Disorders
24 Anxiety Disorders
25 Mood Disorders
25.1 Major Depression
25.2 Dysthymic Disorder
25.3
Bipolar Disorder
26 Suicide and Attempted Suicide
27 Anorexia Nervosa, Bulimia, and Binge Eating
28 Disruptive Behavioral Disorders
29 Pervasive Developmental Disorders and Childhood Psychosis
29.1 Autistic Disorder
29.2 Asperger?s Disorder
29.3 Childhood Disintegrative
Disorder
29.4 Rett's Disorder
29.5 Childhood Schizophrenia
29.6 Acute Phobic Hallucinations
30 Patterns of Development and Function in
the School-Aged Child
31 Attention Deficit Hyperactivity Disorder
32 Specific Reading Disability
32.1 Language Development and Communication
Disorders
PART IV: Children with Special Needs
33 Adoption
34 Foster Care
35 Impact of Violence on Children
35.1
School Violence and Bullying
35.2 Effect of War on Children
36 Abuse and Neglect of Children
36.1 Sexual Abuse
36.2 Munchausen Syndrome
by Proxy
36.3 Parental Styles
37 Failure to Thrive
38 Developmental Disabilities and Chronic Illness
38.1 Mental Retardation (Intellectual
Disability)
39 Organ Transplantation
40 Pediatric Palliative Care: The Care of Children with Life-Limiting Illness
40.1 Grief and Bereavement
Part V: Nutrition
41 Nutritional Requirements
42 The Feeding of Infants and Children
43 Food Insecurity, Hunger, and Undernutrition
44 Overweight and Obesity
45 Vitamin A Deficiency and Excess
46 Vitamin B Complex Deficiency and Excess
46.1 Thiamin (Vitamin B-1)
46.2
Riboflavin (Vitamin B-2)
46.3 Niacin
46.4 Vitamin B-6 (Pyridoxine)
46.5 Biotin
46.6 Folate
46.7 Vitamin B-12 (Cobalamin)
47 Vitamin C
Deficiency (Ascorbic Acid)
48 Rickets and Hypervitaminosis D
49 Vitamin E Deficiency
50 Vitamin K Deficiency
51 Micronutrient Deficiency
Part VI: The Pathophysiology of Body Fluids and Fluid Therapy
52 Electrolyte and Acid-Base Disorders
52.1 Composition of Body
Fluids
52.2 Regulation of Osmolality and Volume
52.3 Sodium
52.4 Potassium
52.5 Magnesium
52.6 Phosphorus
52.7 Acid-Base Balance
53 Maintenance
and Replacement Therapy
54 Deficit Therapy
55 Fluids and Electrolyte Treatment of Specific Disorders
55.1 Acute Diarrhea and Oral Rehydration
55.2 Diarrhea in Chronically Malnourished Children
55.3 Pyloric Stenosis
55.4 Perioperative Fluids
Part VII: Pediatric Drug
Therapy
56 Pharmacogenetics, Pharmacogenomics, and Pharmacoproteins
57 Principles of Drug Therapy
58 Poisonings
59 Herbal Medicines
Part VIII: Critical Care Medicine
60 Evaluation of the Sick Child in the Office and Clinic
61 Injury Control
62 Emergency
Medical Services for Children
63 Interfacility Transfer of the Critically Ill Infant and Child
64 Monitoring Techniques for the Critically
Ill Infant and Child
65 Scoring Systems and Predictors of Mortality
66 Pediatric Emergencies and Resuscitation
67 Neurologic Emergencies
and Stabilization
67.1 Brain Death
68 Shock
69 Respiratory Distress and Failure
70 Mechanical Ventilation
70.1 Chronic Mechanical Ventilation
71 Acute Care of the Multiple Trauma Victim
72 Nutritional Stabilization
73 Drowning
74 Burn injuries
75 Cold Injuries
76 Anesthesia
and Perioperative Care
77 Pediatric Pain Management
Part IX: Human Genetics
78 The Genetic Approach in Pediatric Medicine
79 The Human Genome
80 Patterns of Genetic Transmission
81 Cytogenetics
82 Genetics of Common Disorders: Diagnosis and Management
83
Integration of Genetics into Pediatric Practice
Part X: Metabolic Diseases
84 An Approach to Inborn Errors of Metabolism
85 Defects in Metabolism of Amino Acids
85.1 Phenylalanine
85.2 Tyrosine
85.3 Methionine
85.4 Cysteine/Cystine
85.5 Tryptophan
85.6
Valine, Leucine, Isoleucine, and Related Organic Acidemias
85.7 Glycine
85.8 Serine
85.9 Proline
85.1-0 Glutamic Acid
85.11 Urea Cycle
and Hyperammonemia (Arginine, Citrulline, Ornithine)
85.12 Histidine
85.13 Lysine
85.14 Aspartic Acid (Canavan Disease)
86 Defects in
Metabolism of Lipids
86.1 Disorders of Mitochondrial Fatty Acid β-Oxidation
86.2 Disorders of Very Long Chain Fatty Acids
86.3 Disorders
of Lipoprotein Metabolism and Transport: Epidemiology of Blood Lipids and Cardiovascular Disease
86.4 Lipidoses
86.5 Mucolipidoses
87
Defects in Metabolism of Carbohydrates
87.1 Glycogen Storage Diseases
87.2 Defects in Galactose Metabolism
87.3 Defects in Fructose Metabolism
87.4 Defects in Intermediary Carbohydrate Metabolism Associated with Lactic Acidosis
87.5 Defects in Pentose Metabolism
87.6 Disorders
of Glycoprotein Degradation and Structure
88 Mucopolysaccharidoses
89 Disorders of Purine and Pyrimidine Metabolism
90 Progeria
91 The
Porphyrias
92 Hypoglycemia
Part XI: Perinatal and Neonatal Medicine
93 Overview of Mortality
and Morbidity
94 The Newborn Infant
94.1 History in Neonatal Pediatrics
94.2 Physical Examination of the Newborn Infant
94.3 Routine
Delivery Room Care
94.4 Nursery Care
94.5 Parent-Infant Bonding
95 High-Risk Pregnancies
96 The Fetus
96.1 Fetal Growth and Maturity
96.2 Fetal Distress
96.3 Maternal Disease and the Fetus
96.4 Maternal Medication and Toxin Exposure and the Fetus
96.5 Teratogens
96.6
Radiation
96.7 Intrauterine Diagnosis of Fetal Disease
96.8 Treatment and Prevention of Fetal Disease
97 The High-Risk Infant
97.1 Multiple
Gestation Pregnancies
97.2 Prematurity and Intrauterine Growth Retardation
97.3 Post-Term Infants
97.4 Large for Gestational Age
97.5
Infant Transport
98 Clinical Manifestations of Diseases in the Newborn Period
99 Nervous System Disorders
99.1 The Cranium
99.2 Traumatic,
Epidural, Subdural, and Subarachnoid Hemorrhage
99.3 Intracranial-Intraventricular Hemorrhage and Periventricular Leukomalacia
99.4 Brain
Injury from Inflammation, Infection, and Medications
99.5 Hypoxia-Ischemia
99.6 Spine and Spinal Cord
99.7 Peripheral Nerve Injuries
100 Delivery Room Emergencies
101 Respiratory Tract Disorders
101.1 Transition to Pulmonary Respiration
101.2 Apnea
101.3 Congenital
Central Hypoventilation Syndrome
101.4 Respiratory Distress Syndrome (Hyaline Membrane Disease)
101.5 Transient Tachypnea of the Newborn
101.6 Aspiration of Foreign Material (Fetal Aspiration Syndrome, Aspiration Pneumonia)
101.7 Meconium Aspiration
101.8 Persistent Pulmonary
Hypertension of the Newborn (Persistent Fetal Circulation)
101.9 Diaphragmatic Hernia
101.10
Foramen of Morgagni Hernia
101.11 Paraesophageal Hernia
101.12 Eventration
101.13 Extrapulmonary Extravasation of Air (Pneumothorax,
Pneumomediastinum, Pulmonary Interstitial Emphysema)
101.14 Pulmonary Hemorrhage
102 Digestive System Disorders
102.1 Meconium Ileus
in Cystic Fibrosis
102.2 Neonatal Necrotizing Enterocolitis (NEC)
102.3 Jaundice and Hyperbilirubinemia in the Newborn
102.4 Kernicterus
103 Blood Disorders
103.1 Anemia in the Newborn Infant
103.2 Hemolytic Disease of the Newborn (Erythroblastosis Fetalis)
103.3 Plethora
in the Newborn Infant (Polycythemia)
103.4 Hemorrhage in the Newborn Infant
104 Genitourinary System
105 The Umbilicus
106 Metabolic
Disturbances
106.1 Maternal Selective Serotonin Reuptake Inhibitors and Neonatal Behavioral Syndromes
106.2 Fetal Alcohol Syndrome
107
The Endocrine System
107.1 Infants of Diabetic Mothers
107.2 Hypoglycemia
108 Dysmorphology
109 Infections of the Neonatal Infant
109.1
Pathogenesis and Epidemiology
109.2 Modes of Transmission and Pathogenesis
109.3 Immunity
109.4 Etiology of Fetal and Neonatal Infection
109.5 Epidemiology of Early- and Late-Onset Neonatal Infections
109.6 Clinical Manifestations of Transplacental Intrauterine Infections
109.7 Diagnosis
109.8 Treatment
109.9 Complications and Prognosis
109.1'0 Prevention
Part XII: Adolescent Medicine
110 The Epidemiology of Adolescent Health Problems
111 Delivery of Health Care to Adolescents
111.1 Legal Issues
111.2 Screening Procedures
111.3 Health Enhancement
112 Violent Behavior
113 Substance Abuse
113.1 Alcohol
113.2 Tobacco
113.3 Marijuana
113.4 Volatile Inhalants
113.5 Hallucinogens
113.6 Cocaine
113.7 Amphetamines
113.8 Opiates
113.9 Anabolic Steroids
114 The Breast
115 Menstrual Problems
115.1
Amenorrhea
115.2 Abnormal Uterine Bleeding
115.3 Dysmenorrhea
115.4 Premenstrual Syndrome
116 Contraception
116.1 Barrier Methods
116.2
Spermicides
116.3 Combination Methods
116.4 Hormonal Methods
116.5 Emergency Contraception
116.6 Intrauterine Devices
117 Adolescent
Pregnancy
118 Adolescent Rape
119 Sexually Transmitted Infections
120 Chronic Fatigue Syndrome
Part XIII: Immunology
Section 1: Evaluation of the Immune Systems
121 Evaluation of Suspected ImmunodeficiencySection 2: The T-, B-, and NK-Cell
Systems
122 T Lymphocytes, B Lymphocytes, and Natural Killer Cells
123 Primary Defects of Antibody
Production
123.1 Treatment of B-Cell Defects
124 Primary Defects of Cellular Immunity
125 Primary Combined Antibody and Cellular Immunodeficiencies
125.1 Severe Combined Immunodeficiency (SCID)
125.2 Combined Immunodeficiency (CID)
125.3 Defects of Innate Immunity
125.4 Treatment
of Cellular or Combined Immunodeficiency
125.5 Immune Dysregulation with Autoimmunity or LymphoproliferationSection 3: The Phagocytic
System
126 Neutrophils
127 Monocytes and Macrophages and Dendritic Cells
128 Eosinophils
129 Disorders of Phagocyte Function
130 Leukopenia
131 Leukocytosis Section 4: The Complement System
132 The Complement System
133 Disorders of the Complement System
133.1 Evaluation
of the Complement System
133.2 Genetic Deficiencies of Complement Components
133.3 Deficiencies of Plasma, Membrane, or Serosal Complement
Control Proteins
133.4 Secondary Disorders of Complement
133.5 Treatment of Complement DisordersSection 5:
134 Principles and
Clinical Indications
135 HSCT from Alternative Sources and Donors
136 Graft vs Host Disease (GVHD) and Rejection
137 Infectious Complications
of HSCT
138 Late Effects of HSCT
Part XIV: Allergy
139 Allergy and the Immunologic Basis of Atopic Disease
140 Diagnosis
of Allergic Disease
141 Principles of Treatment of Allergic Disease
142 Allergic Rhinitis
143 Childhood Asthma
144 Atopic Dermatitis
(Atopic Eczema)
145 Insect Allergy
146 Ocular Allergies
147 Urticaria and Angioedema (Hives)
148 Anaphylaxis
149 Serum Sickness
150
Adverse Reactions to Foods
151 Adverse Reactions to Drugs
Part XV: Rheumatology
152 Evaluation of Suspected Rheumatic
Disease
153 Treatment of Rheumatic Diseases
154 Juvenile Rheumatoid Arthritis
155 Ankylosing Spondylitis and Other Spondyloarthropathies
156 Reactive Arthritis
157 Systemic Lupus Erythematosus
157.1 Neonatal Lupus
158 Juvenile Dermatomyositis
159 Scleroderma and Raynaud
Syndrome
160 BehVet?s Disease
161 Sjogren?s Syndrome
162 Hereditary Periodic Fever Syndromes
163 Amyloidosis
164 Sarcoidosis
165 Kawasaki
Disease
166 Vasculitis Syndromes
166.1 Henoch-Schonlein Purpura
166.2 Takayasu Arteritis
166.3 Polyarteritis Nodosa
166.4 Wegener Granulomatosis
166.5 Other Vasculitic Syndromes
167 Musculoskeletal Pain Syndromes
167.1 Fibromyalgia
167.2 Complex Regional Pain Syndrome (Reflex Sympathetic
Dystrophy
167.3 Erythromelalgia
168 Miscellaneous Conditions Associated With Arthritis
Part XVI: Infectious Diseases
Section 1. General Considerations
169 Diagnostic MicrobiologySection 2. Preventive Measures (NEW)
170 (NEW) Immunization
Practices
170.1 (NEW) International Immunization Practices
171 Infection Control and Prophylaxis
172 Childcare and Communicable Diseases
173 Health Advice for Children Traveling Internationally
174 Fever
175 Fever Without a Focus
176 Sepsis, Septic Shock, and System Inflammatory
Response Syndrome (SIRS)
177 Infections in Immunocompromised Persons
178 Infections Associated with Medical DevicesSection 3.
Antibiotic Therapy (NEW)
179 Principles of Antibacterial Therapy
Section 4. Gram-Positive Bacterial Infections
180 Staphylococcus
180.1 Staphylococcus aureus
180.2 Toxic Shock Syndrome
180.3 Coagulase-Negative Staphylococci
181 Streptococcus pneumoniae (Pneumococcus)
182 Group A Streptococcus
182.1 Rheumatic Fever
183 Group B Streptococcus
184 Non?Group A or B Streptococcus
184 Enterococcus
186 Diphtheria
(Corynebacterium diphtheriae)
187 Listeria monocytogenes
188 Actinomyces
189 NocardiaSection 5. Gram Negative Bacterial Infections
190 Neisseria meningitidis (Meningococcus)
191 Neisseria gonorrhoeae (Gonococcus)
192 Haemophilus influenzae
193 Chancroid (Haemophilus
ducreyi)
194 Pertussis (Bordetella pertussis and B. parapertussis)
195 Salmonella
195.1 Nontyphoidal Salmonellosis
195.2 Enteric Fever
(Typhoid Fever)
196 Shigella
197 Escherichia coli
198 Cholera (Vibrio cholerae)
199 Campylobacter
200 Yersinia
200.1 Yersinia enterocolitica
200.2 Yersinia pseudotuberculosis
200.3 Plague (Yersinia pestis)
201 Aeromonas and Plesiomonas
201.1 Aeromonas
201.2 Plesiomonas shigelloides
202 Pseudomonas, Burkholderia, and Stenotrophomonas
202.1 Pseudomonas aeruginosa
202.2 Burkholderia
202.3 Stenotrophomonas
203 Tularemia
(Francisella tularensis)
204 Brucella
205 Legionella
206 Bartonella
206.1 Bartonellosis (Bartonella bacilliformis)
206.2 Cat-Scratch
Disease (Bartonella henselae)
206.3 Trench Fever (Bartonella quintana)
206.4 Bacillary Angiomatosis and Bacillary Peliosis Hepatis (Bartonellahenselae
and Bartonella quintana)Section 6: Anaerobic Bacterial Infections
207 Botulism (Clostridium botulinum)
208 Tetanus (Clostridium
tetani)
209 Pseudomembranous Colitis (Clostridium difficile)
210 Other Anaerobic InfectionsSection 7: Mycobacterial Infections
211 (NEW) Principles of Antimycobacterial Therapy
212 Tuberculosis (Mycobacterium tuberculosis)
213 Hansen Disease (Mycobacterium leprae)
214 Nontuberculous MycobacteriaSection 8. Spirochectal Infections
215 Syphilis (Treponema pallidum)
216 Nonvenereal Treponemal
Infections
216.1 Yaws (Treponema pertenue)
216.2 Bejel Endemic Syphilis (Treponema pallidum subsp. endemicum)
216.3 Pinta (Treponema
carateum)
217 Leptospira
218 Relapsing Fever (Borrelia)
219 Lyme Disease (Borrelia burgdorferi)Section 9. Mycroplasmal Infections
220 Mycoplasma pneumoniae
221 Genital Mycoplasmas (Mycoplasma hominis, Mycoplasma Genitalium, and Ureaplasma urealyticum)Section
10. Chlamydial Infections
222 Chlamydiophila pneumoniae
223 Chlamydia trachomatis
223.1 Trachoma
223.2 Genital Tract Infections
223.3 Conjunctivitis and Pneumonia in Newborns
223.4 Lymphogranuloma Venereum (LGV)
224 Psittacosis (Chlamydia psittaci)Section 11. Rickettsial Infections
225 Spotted Fever Group Rickettsioses
225.1 Rocky Mountain Spotted Fever (Rickettsia rickettsii)
225.2 Mediterranean
Spotted Fever or Boutonneuse Fever (Rickettsia conorii)
225.3 Rickettsialpox (Rickettsia akari)
226 Scrub Typhus (Orientia tsutsugamushi)
227 Typhus Group Rickettsioses
227.1 Murine Typhus (Rickettsia typhi)
227.2 Epidemic Typhus (Rickettsia prowazekii)
228 Ehrlichioses
and Anaplasmosis
229 Q Fever (Coxiella burnetii)Section 12. Fungal Infections
230 Principles of Antifungal Therapy
231 Candida
231.1 Neonatal Infections
231.2 Infections in Immunocompetent Children and Adolescents
231.3 Infections in Immunocompromised Children
and Adolescents
231.4 Chronic Mucocutaneous Candidiasis
232 Cryptococcus neoformans
233 Malassezia
234 Aspergillus
234.1 Hypersensitivity
Syndromes
234.2 Saprophytic (Noninvasive) Syndromes
234.3 Invasive Disease
235 Histoplasmosis (Histoplasma capsulatum)
236 Blastomycosis
(Blastomyces dermatitidis)
237 Coccidioidomycosis (Coccidioides immitis)
238 Paracoccidioides brasiliensis
239 Sporotrichosis (Sporothrix
schenckii)
240 Zygomycosis (Mucormycosis)
241 Pneumocystis carinii (P. jiveci)Section 13. Viral Infections
242 Principles of
Antiviral Therapy
243 Measles
244 Rubella
245 Mumps 246 Polioviruses
247 Nonpolio Enteroviruses
248
Parvovirus B19
249 Herpes Simplex Virus
250 Varicella-Zoster Virus
251 Epstein-Barr Virus
252 Cytomegalovirus
253 Roseola (Human Herpesviruses
6, 7)
254 Human Herpesvirus 8
255 Influenza Viruses
256 Parainfluenza Viruses
257 Respiratory Syncytial Virus
258 Human Metapneumovirus
259 Adenoviruses
260 Rhinoviruses
261 Coronavirus
261.1 Severe Acute Respiratory Syndrome
(SARS)-associated corona virus
262 Rotaviruses, Calicivirus, and Astrovirus (new title)
263 Human Papillomaviruses
264 Arboviral
Encephalitis in North America
265 Arboviral Encephalitis Outside North America
265.1 Venezuelan Equine Encephalitis
265.2 Japanese Encephalitis
265.3 Tick-Borne Encephalitis
266 Dengue Fever and Dengue Hemorrhagic Fever
267 Yellow Fever
268 Other Viral Hemorrhagic Fevers
269 Lymphocytic Choriomeningitis Virus (LCMV)
270 Hantavirus
Pulmonary Syndrome
271 Rabies
272 Polyomaviruses (JC virus and BK Virus)
273 Acquired Immunodeficiency
Syndrome (Human Immunodeficiency Virus)
274 Human T-Cell Lymphotropic Viruses Types I and II
275 Transmissible Spongiform
Encephalopathies Section 14. Antiparasitic Therapy (NEW)276 Principles of Antiparasitic TherapySection 15.
Protozoan Diseases
277 Primary Amebic Meningoencephalitis
278 Amebiasis
279 Giardiasis and Balantidiasis
279.1 Giardia lamblia
279.2
Balantidiasis
280 Cryptosporidium, Isospora, Cyclospora, and Microsporidia
281 Trichomoniasis (Trichomonas vaginalis)
282 Leishmaniasis
(Leishmania)
283 African Trypanosomiasis (Sleeping Sickness; Trypanosoma brucei complex)
284 American Trypanosomiasis (Chagas Disease;
Trypanosoma cruzi)
285 Malaria (Plasmodium)
286 Babesiosis (Babesia)
287 Toxoplasmosis (Toxoplasma gondii)Section 16. Helminthic
Diseases
288 Ascariasis (Ascaris lumbricoides)289 Hookworms (Necator americanus and Ancylostoma)
289.1 Cutaneous Larva Migrans
290
Trichuriasis (Trichuris trichuria)
291 Enterobiasis (Enterobius vermicularis)
292 Strongyloidiasis (Strongyloides stercoralis)
293 Lymphatic
Filariasis (Brugia malayi, B. timori, and Wuchereria bancrofti)
294 Other Tissue Nematodes
295 Toxocariasis (Visceral and Ocular Larva
Migrans)
296 Trichinosis (Trichinella spiralis)
297 Schistosomiasis (Schistosoma)
298 Flukes (Liver, Lung, and Intestinal)
299 Adult
Tapeworm Infections
300 Cysticercosis
301 Echinococcosis (Echinococcus granulosus and E. multilocularis)
Part XVII: The Digestive
System
Section 1. Clinical Manifestations of Gastrointestinal Disease
302 Normal Digestive Tract Phenomena
303 Major
Symptoms and Signs of Digestive Tract DisordersSection 2. The Oral Cavity
304 Development and Developmental Anomalies of the
teeth
305 Disorders of the Oral Cavity Associated with Other Conditions
306 Malocclusion
307 Cleft Lip and Palate
308 Syndromes with
Oral Manifestations
309 Dental Caries
310 Periodontal Diseases
311 Dental Trauma
312 Common Lesions of the Oral Soft Tissues
313 Diseases
of the Salivary Glands and Jaws
314 Diagnostic Radiology in Dental AssessmentSection 3. The Esophagus
315 Embryology, Anatomy,
and Function of the Esophagus
315.1 Common Clinical Manifestations and Diagnostic Aids
316 Congenital Anomalies: Esophageal Atresia and
Tracheoesophageal Fistula
316.1 Congenital Anomalies: Laryngotracheoesophageal Clefts
317 Obstructing and Motility Disorders of the Esophagus
318 Dysmotility
319 Hiatal Hernia
320 Gastroesophageal Reflux Disease (GERD)
320.1 Complications of GERD
321 Non-GERD Esophagitis
322
Esophageal Perforation
323 Esophageal Varices
324 Ingestions
324.1 Foreign Bodies in the Esophagus
324.2 Caustic IngestionsSection
4. Stomach and Intestines
325 Normal Development, Structure, and Function
326 Pyloric Stenosis and Other Congenital Anomalies of
the Stomach
326.1 Hypertropic Pyloric Stenosis
326.2 Congenital Gastric Outlet Obstruction
326.3 Gastric Duplication
326.4 Gastric Volvulus
326.5 Hypertrophic Gastropathy
327 Intestinal Atresia, Stenosis, and Malrotation
327.1 Duodenal Obstruction
327.2 Jejunal and Ileal Atresia
and Obstruction
327.3 Malrotation
328 Intestinal Duplications, Meckel Diverticulum, and Other Remnants of the Omphalomesenteric Duct
328.1 Intestinal Duplication
328.2 Meckel Diverticulum and Other Remnants of the Omphalomesenteric Duct
329 Motility Disorders and Hirschsprung
Disease
329.1 Chronic Intestinal Pseudo-Obstruction
329.2 Functional Constipation
329.3 Congenital Aganglionic Megacolon (Hirschsprung
Disease)
329.4 Intestinal Neuronal Dysplasia
329.5 Superior Mesenteric Artery Syndrome, Wilkie Syndrome, Cast Syndrome, Arteriomesenteric
Duodenal Compression Syndrome
330 Ileus, Adhesions, Intussusception, and Closed-Loop Obstructions
330.1 Ileus
330.2 Adhesions
330.3 Intussusception
330.4 Closed-Loop Obstructions
331 Foreign Bodies and Bezoars
331.1 Foreign Bodies in the Stomach and Intestine
331.2 Bezoars
332 Peptic
Ulcer Disease in Children
332.1 Zollinger-Ellison Syndrome
333 Inflammatory Bowel Disease
333.1 Chronic Ulcerative Colitis
333.2 Crohn
Disease (Regional Enteritis, Regional lleitis, Granulomatous Colitis)
333.3 Behcet Syndrome
334 Food Allergy (Food Hypersensitivity)
334.1 Eosinophilic Gastroenteritis
335 Disorders of Malabsorption
335.1 Evaluation of Children with Suspected Intestinal Malabsorption
335.2 Gluten-Sensitive Enteropathy (Celiac Disease)
335.3 Other Malabsorptive Sydromes
335.4 Intestinal Infections Associated with Malabsorption
335.5 Immunodeficiency Disorders
335.6 Immunoproliferative Small Intestinal Disease
335.7 Short Bowel Syndrome
335.8 Chronic Malnutrition
335.9 Enzyme Deficiencies
335.1-0 Liver and Biliary Disorders Causing Malabsorption
335.11 Defects of Absorption or Transport
336 Intestinal
Transplantation in Children
337 Acute Gastroenteritis in Children (new)
337.1 Probiotics in Gastrointestinal Disorders (new)
338 Chronic
Diarrhea
338.1 Diarrhea from Hormone-Secreting Tumors
339 Recurrent Abdominal Pain of Childhood
340 Acute Appendicitis
341 Surgical Conditions
of the Anus, Rectum, and Colon
341.1 Anorectal Malformations
341.2 Anal Fissure
341.3 Perianal Abscess and Fistula
341.4 Hemorrhoids
341.5 Rectal Prolapse
341.6 Pilonidal Sinus and Abscess
342 Tumors of the Digestive Tract
343 Inguinal Hernias Section 5.
Exocrine Pancreas
344 Embryology, Anatomy, and Physiology
344.1 Anatomic Abnormalities
344.2 Physiology
345 Pancreatic Function Tests
346 Disorders of the Exocrine Pancreas
347 Treatment of Pancreatic Insufficiency
348 Pancreatitis
348.1 Acute Pancreatitis
348.2 Chronic
Pancreatitis
349 Pseudocyst of the Pancreas
350 Pancreatic TumorsSection 6. The Liver and Biliary System
351 Morphogenesis
of the Liver and Biliary System
352 Manifestations of Liver Disease
352.1 Evaluation of Patients with Possible Liver Dysfunction
353
Cholestasis
353.1 Neonatal Cholestasis
353.2 Cholestasis in the Older Child
354 Metabolic Diseases of the Liver
354.1 Inherited Deficient
Conjugation of Bilirubin (Familial Nonhemolytic Unconjugated Hyperbilirubinemia)
354.2 Wilson Disease
354.3 Indian Childhood Cirrhosis
354.4 Neonatal Iron Storage Disease (NISD)
354.5 Miscellaneous Metabolic Diseases of the Liver
355 Viral Hepatitis
356 Liver Abscess
357 Liver Disease Associated with Systemic Disorders
358 Mitochondrial Hepatopathies
359 Autoimmune and Chronic Hepatitis
360 Drug- and
Toxin-Induced Liver Injury
361 Fulminant Hepatic Failure
362 Cystic Diseases of the Biliary Tract and Liver
363 Diseases of the Gallbladder
364 Portal Hypertension and Varices
365 Liver TransplantationSection 7. Peritoneum
366 Malformations
367 Ascites
367.1 Chylous
Ascites
368 Peritonitis
368.1 Acute Primary Peritonitis
368.2 Acute Secondary Peritonitis
368.3 Acute Secondary Localized Peritonitis
(Peritoneal Abscess)
369 Epigastric Hernia
369.1 Incisional Hernia
Part XVIII: Respiratory System
Section 1.
Development and Function
370 Respiratory Pathophysiology and Regulation
370.1 Lung Volumes and Capacities in Health and Disease
370.2
Chest Wall
370.3 Pulmonary Mechanics and Work of Breathing in Health and Disease
370.4 Airway Dynamics in Health and Disease
370.5 Interpretation
of Clinical Signs to Localize the Site of Pathology
370.6 Ventilation-Perfusion (V/Q) Relationship in Health and Disease
370.7 Gas Exchange
in Health and Disease
370.8 Interpretation of Blood Gases
370.9 Pulmonary Vasculature in Health and Disease
370.1-0 Immune Response of
the Lung to Injury
370.11 Regulation of Respiration
371 Diagnostic Approach to Respiratory Disease
372 Sudden Infant Death SyndromeSection
2. Disorders of the Respiratory Tract
373 Congenital Disorders of the Nose
374 Acquired Disorders of the Nose
374.1 Foreign Body
374.2 Epistaxis
375 Nasal Polyps
376 The Common Cold
377 Sinusitis
378 Acute Pharyngitis
379 Retropharyngeal Abscess, Lateral Pharyngeal
(Parapharyngeal) Abscess, and Peritonsillar Cellulitis/Abscess
380 Tonsils and Adenoids
381 Chronic or Recurrent Respiratory Symptoms
382 Acute Inflammatory Upper Airway Obstruction (Croup, Epiglottitis, Laryngitis, and Bacterial Tracheitis)
382.1 Infectious Upper Airway
Obstruction
382.2 Bacterial Tracheitis
383 Congenital Anomalies of the Larynx, Trachea, and Bronchi
383.1 Laryngomalacia
383.2 Congenital
Subglottic Stenosis
383.3 Vocal Cord Paralysis
383.4 Congenital Laryngeal Webs and Atresia
383.5 Congenital Subglottic Hemangioma
383.6
Laryngoceles and Saccular Cysts
383.7 Posterior Laryngeal Cleft (PLC) and Laryngotracheoesophageal Cleft (LTEC)
383.8 Vascular and Cardiac
Anomalies
383.9 Tracheal Stenoses, Webs, and Atresia
383.1-0 Foregut Cysts
383.11 Tracheomalacia and Bronchomalacia
384 Foreign Bodies
of the Airway
384.1 Laryngeal Foreign Bodies
384.2 Tracheal Foreign Bodies
384.3 Bronchial Foreign Bodies
385 Laryngotracheal Stenosis,
Subglottic Stenosis
385.1 Congenital Subglottic Stenosis
385.2 Acquired Laryngotracheal Stenosis
386 Bronchomalacia and Tracheomalacia
387 Neoplasms of the Larynx, Trachea, and Bronchi
387.1 Vocal Nodules
387.2 Recurrent Respiratory Papillomatosis (RRP)
387.3 Congenital
Subglottic Hemangioma
387.4 Vascular Anomalies
387.5 Other Laryngeal Neoplasms
387.6 Tracheal Neoplasms
387.7 Bronchial Tumors
388 Wheezing,
Bronchiolitis, and Bronchitis
388.1 Wheezing in Infants and Bronchiolotis
388.2 Bronchitis
389 Emphysema and Overinflation
390 α1-Antitrypsin
Deficiency and Emphysema
391 Other Distal Airway Diseases
391.1 Bronciolitis Obliterans
391.2 Follicular Bronchitis
391.3 Pulmonary Alveolar
Microlithiasis
392 Congenital Disorders of the Lung
392.1 Pulmonary Agenesis and Aplasia
392.2 Pulmonary Hypoplasia
392.3 Cystic Adenomatoid
Malformation
392.4 Pulmonary Sequestration
392.5 Bronchogenic Cysts
392.6 Congenital Pulmonary Lymphangiectasia
392.7 Lung Hernia
392.8
Other Congenital Malformations of the Lung
393 Pulmonary Edema
394 Aspiration Syndromes
395 Chronic Recurrent Aspiration
396 Parenchymal
Disease with Prominent Hypersensitivity, Eosinophilic Infiltration, or Toxin-Mediated Injury
396.1 Hypersensitivity to Inhaled Materials
396.2 Silo Filler Disease
396.3 Paraquat Lung
396.4 Eosinophilic Lung Disease (Formerly Loffler Syndrome)
397 Pneumonia
398 Bronchiectasis
399 Pulmonary Abscess
400 Cystic Fibrosis
401 Primary Ciliary Dyskinesia (Immotile Cilia Syndrome)
402 Interstitial Lung Diseases
403
Pulmonary Alveolar Proteinosis
404 Inherited Disorders of Surfactant Metabolism
405 Pulmonary Hemosiderosis
406 Pulmonary Hemorrhage,
Embolism, and Infarction
406.1 Pulmonary Embolus and Infarction
406.2 Pulmonary Hemorrhage and Hemoptysis
407 Atelectasis
408 Pulmonary
Tumors
409 Pleurisy
409.1 Dry or Plastic Pleurisy
409.2 Serofibrinous Pleurisy
409.3 Purulent Pleurisy or Empyema
410 Pneumothorax
411
Pneumomediastinum
412 Hydrothorax
413 Hemothorax
414 Chylothorax
415 Bronchopulmonary Dysplasia
416 Skeletal Diseases Influencing Pulmonary
Function
416.1 Pectus Excavatum (Funnel Chest)
416.2 Pectus Carinatum and Sternal Clefts
416.3 Asphyxiating Thoracic Dystrophy (Thoracic-Pelvic-Phalangeal
Dystrophy)
416.4 Achondroplasia
416.5 Kyphoscoliosis: Adolescent Idiopathic Scoliosis and Congential Scoliosis
416.6 Congenital Rib Anomalies
417 Neuromuscular Diseases with Pulmonary Consequences
418 Extrapulmonary Diseases with Pulmonary Manifestations
419 Chronic Severe
Respiratory Insufficiency
Part XIX: The Cardiovascular System
Section 1. Developmental Biology of the Cardiovascular
System
420 Cardiac Development
420.1 Early Cardiac Morphogenesis
420.2 Cardiac Looping
420.3 Cardiac Septation
420.4 Aortic Arch Development
420.5 Cardiac Differentiation
420.6 Developmental Changes in Cardiac Function
421 The Fetal to Neonatal Circulatory Transition
421.1
The Fetal Circulation
421.2 The Transitional Circulation
421.3 The Neonatal Circulation
421.4 Persistent Pulmonary Hypertension of the
Neonate (Persistence of Fetal Circulatory Pathways)
421.5 The Influence of Fetal Environmental Factors on Adult Cardiovascular and Metabolic
DiseaseSection 2. Evaluation of the Cardiovascular System
422 History and Physical Examination
423 Laboratory Evaluation
423.1
Radiologic Assessment
423.2 Electrocardiography
423.3 Hematologic Data
423.4 Echocardiography
423.5 Exercise Testing
423.6 MRI, MRA,
CT, and Radionuclide Studies
423.7 Diagnostic and Interventional Cardiac CatheterizationSection 3. Congenital Heart Diseases
424 Epidemiology of Congenital Heart Disease
425 Evaluation of the Infant or Child with Congenital Heart Disease
426 Acyanotic Congenital
Heart Disease: The Left-to-Right Shunt Lesions
426.1 Atrial Septal Defect
426.2 Ostium Secundum Defect
426.3 Sinus Venosus Atrial Septal
Defect
426.4 Partial Anomalous Pulmonary Venous Return
426.5 Atrioventricular Septal Defects (Ostium Primum and Atrioventricular Canal
or Endocardial Cushion Defects)
426.6 Ventricular Septal Defect
426.7 Supracristal Ventricular Septal Defect with Aortic Insufficiency
426.8 Patent Ductus Arteriosus
426.9 Aorticopulmonary Window Defect
426.1-0 Coronary-Arteriovenous Fistula (Coronary-Cameral Fistula)
426.11 Ruptured Sinus of Valsalva Aneurysm
427 Acyanotic Congenital Heart Disease: The Obstructive Lesions
427.1 Pulmonary Valve Stenosis
with Intact Ventricular Septum
427.2 Infundibular Pulmonary Stenosis and Double-Chamber Right Ventricle
427.3 Pulmonary Stenosis in Combination
with an Intracardiac Shunt
427.4 Peripheral Pulmonary Stenosis
427.5 Aortic Stenosis
427.6 Coarctation of the Aorta
427.7 Coarctation
with Ventricular Septal Defect
427.8 Coarctation with Other Cardiac Anomalies and Interrupted Aortic Arch
427.9 Congenital Mitral Stenosis
427.1-0 Pulmonary Venous Hypertension
428 Acyanotic Congenital Heart Disease: Regurgitant Lesions
428.1 Pulmonary Valvular Insufficiency
and Congenital Absence of the Pulmonary Valve
428.2 Congenital Mitral Insufficiency
428.3 Mitral Valve Prolapse
428.4 Tricuspid Regurgitation
429 Cyanotic Congenital Heart Disease: Evaluation of the Critically Ill Neonate with Cyanosis and Respiratory Distress
430 Cyanotic Congenital
Heart Lesions: Lesions Associated with Decreased Pulmonary Blood Flow
430.1 Tetralogy of Fallot
430...
| Bibliographic details |
Hardbound, 3200 pages, publication date: JUL-2007
ISBN-13: 978-1-4160-2450-7
ISBN-10: 1-4160-2450-6
Imprint: SAUNDERS
|
042/432
Last update: 25 Nov 2009
|
 |
|  |
 |  |  |
 |
|
|  |